STOCK TITAN

Clorox's Laurene E. Peck acquires 1,172 grant shares

The transactions include shares withheld for taxes on both performance stock units and restricted stock.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Clorox (CLX) VP - CAO & Corp Controller Laurene E. Peck acquired 1,172 common shares on October 5, 2026, in settlement of a 2023 Performance Unit Grant that vested that day; she elected to defer the settlement under the 2005 Stock Incentive Plan. Clorox withheld 30 shares for tax obligations related to vesting performance stock units and 339 shares for tax obligations related to vesting restricted stock. Peck also held 100 shares indirectly through Trust of Parent.

Insider Peck Laurene E
Role VP - CAO & Corp Controller
Type Security Shares Price Value
Grant/Award Common Stock F1 1,172 $80.41 $94K
Tax Withholding Common Stock F2 30 $80.41 $2K
Tax Withholding Common Stock F3, F4 339 $80.41 $27K
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 10,017 shares (Direct); Common Stock — 100 shares (Indirect, Trust of Parent)
Footnotes (4)
  1. F1. Settlement of 2023 Performance Unit Grant that vested 10/5/26, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.
  2. F2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.
  3. F3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
  4. F4. Includes 168 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
Performance Unit Grant settlement 1,172 shares Grant vested October 5, 2026
Performance stock unit tax withholding 30 shares October 5, 2026
Restricted stock tax withholding 339 shares October 5, 2026
Indirect holding through Trust of Parent 100 shares October 5, 2026
Dividend reinvestment shares 168 shares Acquired pursuant to the Company's Stock Incentive Plan
Performance Unit Grant financial
"Settlement of 2023 Performance Unit Grant"
restricted stock financial
"vesting of restricted stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
dividend reinvestment feature financial
"pursuant to a dividend reinvestment feature"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLX shares did Laurene E. Peck acquire and have withheld?

Laurene E. Peck acquired 1,172 common shares on October 5, 2026, in settlement of a vested 2023 Performance Unit Grant. Clorox withheld 30 shares for taxes on performance stock units and 339 shares for taxes on restricted stock.

What does Laurene E. Peck's CLX Form 4 say about dividend reinvestment?

It notes 168 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Peck Laurene E

(Last)(First)(Middle)
1221 BROADWAY

(Street)
OAKLAND CALIFORNIA 94612-1888

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
VP - CAO & Corp Controller
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/05/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock10/05/2026A(1)1,172A$80.4110,386D
Common Stock10/05/2026F(2)30D$80.4110,356D
Common Stock10/05/2026F(3)339D$80.4110,017(4)D
Common Stock100ITrust of Parent
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Settlement of 2023 Performance Unit Grant that vested 10/5/26, which the reporting person has elected to defer pursuant to the 2005 Stock Incentive Plan.
2. Withholding of shares by the Company to satisfy tax obligations relating to vesting of performance stock units.
3. Withholding of shares by the Company to satisfy tax obligations relating to vesting of restricted stock.
4. Includes 168 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.
By Jinho Joo, Attorney-in-Fact for10/07/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading